Mr. Tony O'Brien:

The Deputy is referring to recent media reports which seek to make a calculation based on below-the-line offers that may go on between distributors or manufacturers and individual pharmacists, sometimes referred to as two-for-one and three-for-one offers. We reimburse based on list price and would not have visibility of these types of two-for-one or three-for-one offers that periodically - or perhaps even more often than periodically - are in play between distributors and prescribers. Certainly we do not play in that space. We do not see the benefit of that.